1. Wang, Jun-Cheng, Chen, Dong-Ping, Lu, Shi-Xun, Chen, Min-Shan, Zhou, Zhong-Guo. . PIM2 Expression Induced by Proinflammatory Macrophages Suppresses Immunotherapy Efficacy in Hepatocellular Carcinoma. In Cancer research, 82, 3307-3320. doi:10.1158/0008-5472.CAN-21-3899. https://pubmed.ncbi.nlm.nih.gov/35802648/
2. Wang, Yixin, Xiu, Jing, Ren, Chune, Yu, Zhenhai. 2021. Protein kinase PIM2: A simple PIM family kinase with complex functions in cancer metabolism and therapeutics. In Journal of Cancer, 12, 2570-2581. doi:10.7150/jca.53134. https://pubmed.ncbi.nlm.nih.gov/33854618/
3. Tang, Xuming, Cao, Tingting, Zhu, Yun, Huang, Jian-Dong, Guan, Xin-Yuan. 2020. PIM2 promotes hepatocellular carcinoma tumorigenesis and progression through activating NF-κB signaling pathway. In Cell death & disease, 11, 510. doi:10.1038/s41419-020-2700-0. https://pubmed.ncbi.nlm.nih.gov/32641749/
4. Buchacher, Tanja, Shetty, Ankitha, Koskela, Saara A, Elo, Laura L, Lahesmaa, Riitta. 2023. PIM kinases regulate early human Th17 cell differentiation. In Cell reports, 42, 113469. doi:10.1016/j.celrep.2023.113469. https://pubmed.ncbi.nlm.nih.gov/38039135/
5. Ren, Chune, Yang, Tingting, Qiao, Pengyun, Du, Yu, Yu, Zhenhai. 2018. PIM2 interacts with tristetraprolin and promotes breast cancer tumorigenesis. In Molecular oncology, 12, 690-704. doi:10.1002/1878-0261.12192. https://pubmed.ncbi.nlm.nih.gov/29570932/
6. Adam, Kévin, Lambert, Mireille, Lestang, Elsa, Zermati, Yael, Mayeux, Patrick. 2015. Control of Pim2 kinase stability and expression in transformed human haematopoietic cells. In Bioscience reports, 35, . doi:10.1042/BSR20150217. https://pubmed.ncbi.nlm.nih.gov/26500282/
智鼠故事 
